A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C
N/A
The primary objective of this program is to provide DCV for 24 weeks to be ...
Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs
PHASE1
This is open label, phase 1 clinical study to evaluate the safety, tolerabi...
Status
Completed
Location
Regional State Budgetary Healthcare Institution "Smolensk Regional Clinical Hospital"